ClinicalTrials.gg
Enrolling by invitationNCT06291532Updated Oct 8, 2026

Feasibility and Usability of a Virtual Reality System

An interventional study of Rehabilitation with VRRS and Conventional cognitive training in Autism Spectrum Disorder and Intellectual Disability, sponsored by IRCCS Centro Neurolesi Bonino Pulejo. Enrolling by invitation at 1 site in Italy. Open to participants aged 6 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by IRCCS Centro Neurolesi Bonino Pulejo · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Apr 2023, registered Feb 2024).
Updated Oct 8, 2026Study completion movedEligibility revised+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
6 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 90 studies in Autism Spectrum Disorder with a site in Italy — 48 open to participants now, 55 under way, 1 of them phase 3. Autism Spectrum Disorder · Italy.

Planned enrollment
17th of 63
100 · median 50
Started
2023
with 23 others
No phase
51 of 90
30 open now
Primary completion
2025-09
later than 29 of 54 live
Registered
46th of 90
by date
Lead sponsor
5 of 90
IRCCS Centro Neurolesi Bonino Pulejo

Among the 90 studies in Autism Spectrum Disorder with a site in Italy, this one is the 17th largest by planned enrollment of the 63 interventional ones that give a count, is one of 24 that started in 2023, is one of 51 with no phase, reaches primary completion later than 29 of the 54 other live ones, and was the 46th registered.

Autism Spectrum Disorder

1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.

Browse Autism Spectrum Disorder studies →

Open to participants now

48 of the 90 studies in Autism Spectrum Disorder with a site in Italy are open now. Recruiting first, the newest first:

43 more — sign in →

All 48 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.

This study: 6 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 90 studies in Autism Spectrum Disorder with a site in Italy, or all of them as a file.
02

Study summary

Intellectual disability (ID) and autism spectrum disorder (ASD) are often co-occurring neurodevelopmental disorders that require composite intervention. However, standardized rehabilitation programs presented several limitations due to behavioral problems and poor engagement in proposed activity. The Virtual Reality Rehabilitation System (VRRS) is a medical device is recognized as one of the most advanced systems to rehabilitate patients with motor, cognitive, linguistic and behavioral disorders. The use of VRRS offers the opportunity to adapting task parameters according to the patient's performance and the virtual system increases engagement and avoids boredom and frustration. the patients underwent a two months experimental intervention integrated into the regular activity of a semi-residential center for autistic adolescents and young adults.

03

Conditions studied

  • Autism Spectrum Disorder
  • Intellectual Disability
04

Who can participate

The criteria were revised on the registry on Oct 8, 2026. See what changed

Ages eligible
6 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • subjects diagnosed with ASD and ID, according to the criteria of the (DSM-5);
  • age between 6 and 40 years;
  • cognitive level ≤75 Intellectual Quotient
  • signed

Exclusion criteria

Exclusion criteria:

  • subjects without diagnosis of ASD and ID, according to the criteria of the (DSM-5);
  • age not between 6 and 40 years;
  • cognitive level >75 Intellectual Quotient
  • unsigned
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Experimental Group (EG)

    The group consists of patients diagnosed with autism spectrum disorder and intellectual disability who underwent treatment with VRRS

    Device: Rehabilitation with VRRS

  • Active comparator
    Conventional Cognitive Training

    Patients diagnosed with autism spectrum disorder and intellectual disability underwent to conventional cognitive training

    Behavioral: Conventional cognitive training

Interventions

  • DeviceRehabilitation with VRRS

    The patients underwent an experimental intervention lasting two months (9 sessions lasting about 40 minutes) integrated into the regular activity of a semi-residential center for autistic adolescents and young adults. The proposed exercises were 2D and the patient interacted with the scenarios through the touch screen. For all participants, the tasks were the same, but difficulty and duration varied according to the needs and goals to be achieved.

  • BehavioralConventional cognitive training

    Conventional cognitive training consisted of structured paper-and-pencil tasks and therapist-guided activities targeting multiple cognitive domains, including attention, visual-spatial processing, sustained attention, working memory, and problem-solving. These exercises were administered individually by a trained therapist and tailored to each participant's functional level. The intervention lasting two months (9 sessions, lasting about 40 minutes) integrated into regular activity of semi-residential center for autistic adolescents and young adults.

06

What researchers measure

Primary outcomes

  1. Usability questionnaire

    The questionnaire used a 5-point ordinal scale, where 5 is the most favorable score and 1 is the least favorable score; the score 3 corresponds to "no opinion". The questionnaire will be completed by all therapists at the end of the treatment.

    Time frame: T0 (BASELINE) - T1 (SIX MONTHS)

  2. Virtual Reality Rehabilitation System (VRRS) electromedical device parameters: screen attention time

    During the execution of the exercise, the attention time maintained on the screen was recorded.

    Time frame: T0 (BASELINE) -T1 (SIX MONTHS)

  3. Virtual Reality Rehabilitation System (VRRS) electromedical device parameters: the number of repetitions of the exercises.

    During the execution of the exercise, the number of repetitions of the exercises was recorded

    Time frame: T0 (BASELINE) -T1 (SIX MONTHS)

  4. Virtual Reality Rehabilitation System (VRRS) electromedical device parameters:global scores for exercise.

    The total scores obtained were recorded during the execution of the exercise.

    Time frame: T0 (BASELINE) -T1 (SIX MONTHS)

07

Study locations

1 site
08

References and documents

Publications

  • Bernard Paulais MA, Mazetto C, Thiebaut E, Nassif MC, Costa Coelho De Souza MT, Stefani AP, Blanc R, Gattegno MP, Aiad F, Sam N, Belal L, Fekih L, Kaye K, Contejean Y, Wendland J, Barthelemy C, Bonnet-Brilhault F, Adrien JL. Heterogeneities in Cognitive and Socio-Emotional Development in Children With Autism Spectrum Disorder and Severe Intellectual Disability as a Comorbidity. Front Psychiatry. 2019 Jul 19;10:508. doi: 10.3389/fpsyt.2019.00508. eCollection 2019. PubMed 31396112 ↗
  • De Luca R, Bonanno M, Rifici C, Pollicino P, Caminiti A, Morone G, Calabro RS. Does Non-Immersive Virtual Reality Improve Attention Processes in Severe Traumatic Brain Injury? Encouraging Data from a Pilot Study. Brain Sci. 2022 Sep 8;12(9):1211. doi: 10.3390/brainsci12091211. PubMed 36138947 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2023 to primary completion in Sep 2025, 29 months.

Of 806 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's 29 months is above that.

Counting every sponsor, half of 829 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

Completion moved once since we started tracking on Sep 25, 2026: Sep 2025 → Sep 2026, on Oct 8, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 9, 2024
First posted
Mar 4, 2024
StartActual
Apr 1, 2023
Primary completionActual
Sep 30, 2025
CompletionEst.
Sep 30, 2026was Sep 2025
Last update
Oct 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • IRCCS Centro Neurolesi Bonino Pulejo · Messina, Italy
Show 1 removed
  • IRCCS Centro Neurolesi Bonino Pulejo · Messina, Italy
Oct 8, 2026
Study completion
Sep 30, 2025→Sep 30, 2026
Oct 8, 2026
Eligibility
1 inclusion criterion edited; 1 exclusion criterion edited
What changed in the criteria
Inclusion criteria
  • Editedcognitive level <65≤75 Intellectual Quotient
Exclusion criteria
  • Editedcognitive level >6575 Intellectual Quotient
Oct 8, 2026
Interventions
Added Behavioral: Conventional cognitive training. Arms added: Conventional Cognitive Training
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    1 site added, 1 site removed
    Show site
    • IRCCS Centro Neurolesi Bonino Pulejo · Messina, Italy
    Show 1 removed
    • IRCCS Centro Neurolesi Bonino Pulejo · Messina, Italy
    Study completion Sep 30, 2025→Sep 30, 2026
    Eligibility 1 inclusion criterion edited; 1 exclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • Editedcognitive level <65≤75 Intellectual Quotient
    Exclusion criteria
    • Editedcognitive level >6575 Intellectual Quotient
    Interventions Added Behavioral: Conventional cognitive training. Arms added: Conventional Cognitive Training
    + 3 other changes: index terms, verification date and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06291532
Lead sponsor
IRCCS Centro Neurolesi Bonino Pulejo
Responsible party
Francesca Cucinotta (Principal Investigator, IRCCS Centro Neurolesi Bonino Pulejo) — Principal investigator
First posted
Mar 4, 2024
Start date
Apr 1, 2023
Primary completion
Sep 30, 2025
Completion
Sep 30, 2026 (estimated)
Last update
Oct 8, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion